Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Completed 5

Sponsor Class

INDUSTRY 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 53Gastrointestinal 48Lymphoid 45Other hematologic neoplasm 41Genitourinary 37Breast 33Gynecologic 20Myeloid 20Plasma cell 20CNS 18Classical hematology 15Dermatologic 14Endocrine 11Sarcoma 8Head & Neck 7NET 5Other solid neoplasm 5Tumor-Agnostic 4

Conditions

Mesothelioma 2Microsatellite Unstable Colorectal Cancer 1Advanced or Metastatic Solid Tumors 1Advanced Solid Tumors 1

Interventions

Nivolumab 3Ipilimumab 3cobimetinib 2Pemetrexed 2Cisplatin 2relatlimab 1pembrolizumab 1daratumumab 1PM 01183 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Has results × Has announcements × Other solid neoplasm × Clear all
NCT02060188 2025-11-06

CheckMate142

Bristol-Myers Squibb

Phase 2 Completed
385 enrolled 17 charts 2 FDA
GastrointestinalOther solid neoplasm

Microsatellite Unstable Colorectal Cancer

NCT01928394 2024-12-27

A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors

Bristol-Myers Squibb

Phase 1/2 Completed
1,163 enrolled 33 charts 1 FDA
Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT02784171 2024-12-10

Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

Canadian Cancer Trials Group

Phase 2/3 Completed
520 enrolled 16 charts 1 FDA
Other solid neoplasmThoracic

Mesothelioma

NCT02899299 2024-05-21

CheckMate743

Bristol-Myers Squibb

Phase 3 Completed
605 enrolled 17 charts 1 FDA
Other solid neoplasmThoracic

Mesothelioma

NCT02454972 2023-03-02

Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors

PharmaMar

Phase 2 Completed
345 enrolled 34 charts 1 FDA
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡